Dr Michael Mond - Wednesday, 4 November 2026 at 7.30pm

Dr Michael Mond, Endocrinologist

Thyroid nodules in 2026: A practical approach to ultrasound reports, risk stratification and when to refer

Learning outcomes

• Apply the 2025 American Thyroid Association four-tier risk stratification system to interpret thyroid ultrasounds and identify those requiring FNA or surveillance
• List Bethesda cytology categories and describe management options for indeterminate nodules
• Identify red flags on ultrasound and in clinical presentation that require an urgent specialist referral versus routine follow-up
• Describe nodule assessment modifications for special populations including pregnancy and paediatric patients

Biography

I am an endocrinologist with a special interest in the management of thyroid conditions including thyroid nodules and thyroid cancer. I also manage a broad range of endocrine conditions including diabetes, osteoporosis, adrenal and pituitary disorders.

I completed my specialist training at Monash Health and subsequently undertook a PhD at Prince Henry’s Institute of Medical Research (now Hudson Institute) investigating the role of genetic and molecular changes in the development and progression of thyroid tumours. I co-lead the Multidisciplinary Thyroid Clinic at Monash Health and am a lead endocrinologist in the Thyroid Clinic at Eastern Health. I chair multidisciplinary thyroid cancer meetings at both sites.

I consult privately at Cabrini Hospital as well as at Monash Medical Centre and in East Bentleigh.